Share on StockTwits

Research analysts at WallachBeth Capital cut their target price on shares of Mazor Robotics Ltd – (NASDAQ:MZOR) from $26.50 to $23.00 in a report released on Wednesday. The firm currently has a “buy” rating on the stock. WallachBeth Capital’s price target indicates a potential upside of 71.90% from the company’s current price.

Shares of Mazor Robotics Ltd – (NASDAQ:MZOR) opened at 13.38 on Wednesday. Mazor Robotics Ltd – has a one year low of $12.76 and a one year high of $25.61. The stock’s 50-day moving average is $15.40 and its 200-day moving average is $19.52. The company’s market cap is $275.1 million.

Mazor Robotics Ltd – (NASDAQ:MZOR) last announced its earnings results on Tuesday, August 5th. The company reported ($0.09) EPS for the quarter, meeting the Thomson Reuters consensus estimate of ($0.09). The company had revenue of $4.50 million for the quarter, compared to the consensus estimate of $5.79 million. During the same quarter in the prior year, the company posted ($0.02) earnings per share. The company’s quarterly revenue was down 27.4% on a year-over-year basis. Analysts expect that Mazor Robotics Ltd – will post $-0.41 EPS for the current fiscal year.

A number of other firms have also recently commented on MZOR. Analysts at Needham & Company LLC cut their price target on shares of Mazor Robotics Ltd – from $20.00 to $16.00 in a research note on Tuesday. They now have a “buy” rating on the stock. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $23.42.

Mazor Robotics Ltd is an Israel-based company active in the advanced medical sector. It is engaged in the development of miniature semi-robotic, bone-mounted positioning systems for orthopedic procedures.

Receive News & Ratings for Mazor Robotics Ltd - Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics Ltd - and related companies with Analyst Ratings Network's FREE daily email newsletter.